Skip to main content
S 2146 117th Congress Senate Health Administrative law and regulatory procedures Advanced technology and technological innovations Advisory bodies Congressional oversight Department of Health and Human Services Digestive and metabolic diseases Drug safety, medical device, and laboratory regulation Health care coverage and access Health technology, devices, supplies Medical research Medicare

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021

Introduced: June 21, 2021 Introduced by: Collins, Susan M. Republican · Maine See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 21, 2021
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4657)
Jun 21, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021

This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.

Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.

What's happening now June 21, 2021

Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4657)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Shaheen, Jeanne
New Hampshire · Jun 21, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2146: Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2146/
MLA
"S. 2146: Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2146/.
Bluebook (legal)
S. 2146, 117th Cong. (2026), https://openamerica.io/bill/117-S-2146/.
Markdown link
[S. 2146: Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021](https://openamerica.io/bill/117-S-2146/)
Report a problem